All Stories

  1. Enhanced mRNA expression of plasminogen activator inhibitor-1 in livedoid vasculopathy lesions

    Article • Cardiovascular Therapeutics, May 2017, Wiley

    Mehmet Agirbasli, Dr Fatih Göktay

  2. Potential Causes and Implications of Low Target Therapeutic Ratio in Warfarin-Treated Patients for Thrombosis Prophylaxis: A Single-Center Experience

    Article • Clinical and Applied Thrombosis/Hemostasis, March 2017, SAGE Publications

    Mehmet Agirbasli

  3. Metabolic Syndrome: Bridging the Gap from Childhood to Adulthood

    Article • Cardiovascular Therapeutics, January 2016, Wiley

    Mehmet Agirbasli

  4. Heart Failure and Mortality in Patients With Nonvalvular Atrial Fibrillation Started on Novel Oral Anticoagulant Therapy: A Single-Center Experience

    Article • Clinical and Applied Thrombosis/Hemostasis, November 2015, SAGE Publications

    Mehmet Agirbasli

  5. Novel Concepts in Vascular Stent Design: Can Stent be Personalized Through Computational Fluid Dynamics?

    Article • Current Pharmacogenomics and Personalized Medicine, June 2015, Bentham Science Publishers

    Mehmet Agirbasli

  6. Growth Arrest-Specific 6 and Cardiometabolic Risk Factors in Patients with Psoriasis

    Article • Cardiovascular Therapeutics, March 2015, Wiley

    Mehmet Agirbasli

  7. Personalized and Participatory Medicine as a Future Tool to Combat Cardiovascular Disease in Developing Countries

    Article • Current Pharmacogenomics and Personalized Medicine, March 2015, Bentham Science Publishers

    Mehmet Agirbasli

  8. Psoriasis and Atherosclerosis: Is There a Need For Novel Biomarkers Assessing Cardiovascular Risk?

    Article • Current Pharmaceutical Design, February 2014, Bentham Science Publishers

    Mehmet Agirbasli